Nuclear transcription factor-κB as a target for cancer drug development
暂无分享,去创建一个
A Garg | BB Aggarwal | A. Garg | BB Aggarwal
[1] David Baltimore,et al. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism , 1986, Cell.
[2] P. Herrlich,et al. UV-induced transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and UV-induced secretion of an extracellular factor that induces HIV-1 transcription in nonirradiated cells , 1989, Journal of virology.
[3] P. Baeuerle,et al. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B , 1990, Molecular and cellular biology.
[4] C V Jongeneel,et al. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages , 1990, The Journal of experimental medicine.
[5] P. Baeuerle,et al. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.
[6] R. Chaganti,et al. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. , 1991, Cell.
[7] F. Arenzana‐Seisdedos,et al. HIV enhancer activity perpetuated by NF-κB induction on infection of monocytes , 1991, Nature.
[8] R. Chaganti,et al. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50 , 1991, Cell.
[9] J. Whelan,et al. An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. , 1991, Nucleic acids research.
[10] J. D. Thompson,et al. Alterations at the rel locus in human lymphoma. , 1991, Oncogene.
[11] K. Busam,et al. Staphylococcus aureus and derived exotoxins induce nuclear factor kappa B-like activity in murine bone marrow macrophages , 1992, Infection and immunity.
[12] J. McPherson,et al. Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2. , 1992, Genomics.
[13] D. Männel,et al. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells , 1992, The Journal of experimental medicine.
[14] G. Rosen,et al. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). , 1992, The Journal of biological chemistry.
[15] M. Roederer,et al. Antioxidants inhibit stimulation of HIV transcription. , 1993, AIDS research and human retroviruses.
[16] L. Cro,et al. Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies. , 1993, Oncogene.
[17] R. Dalla‐Favera,et al. Chromosomal localization of genes encoding the transcription factors, c-rel, NF-kappa Bp50, NF-kappa Bp65, and lyt-10 by fluorescence in situ hybridization. , 1993, Oncogene.
[18] A. Arnold,et al. PRAD1/lCyclin D1 proto‐oncogene: Genomic organization, 5′ dna sequence, and sequence of a tumor‐specific rearrangement breakpoint , 1993 .
[19] A. Baldwin,et al. Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1. , 1993, The Journal of biological chemistry.
[20] Lozano,et al. A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation , 1993, Molecular and cellular biology.
[21] B. Vandenbunder,et al. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro , 1993, Cell.
[22] J. Folkman. Diagnostic and therapeutic applications of angiogenesis research. , 1993, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.
[23] A. Koong,et al. Hypoxia Causes the Activation of Nuclear Factor κB through the Phosphorylation of IκBα on Tyrosine Residues , 1994 .
[24] I. Verma,et al. Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines , 1994, Molecular and cellular biology.
[25] S. Ghosh,et al. Inhibition of NF-kappa B by sodium salicylate and aspirin. , 1994, Science.
[26] Aseem Kumar,et al. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[27] W. Shearer,et al. Activation of NF-KB and Immunoglobulin Expression in Response to Platelet-Activating Factor in a Human B Cell Line , 1994 .
[28] J. Johnson,et al. 12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter. , 1994, The Journal of biological chemistry.
[29] M. Rocchi,et al. Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2/lyt-10 gene in lymphoid malignancies. , 1994, Blood.
[30] S. Kato,et al. Platelet-Activating Factor (PAF) Positively Auto-Regulates the Expression of Human PAF Receptor Transcript 1 (Leukocyte-Type) Through NF-κB , 1994 .
[31] C. Gélinas,et al. Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells. , 1994, Oncogene.
[32] V. Castronovo,et al. The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines. , 1994, Biochemical pharmacology.
[33] S. Ohno,et al. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. , 1994, Journal of immunology.
[34] Tom Maniatis,et al. The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB , 1994, Cell.
[35] A. Koong,et al. Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. , 1994, Cancer research.
[36] A. Goldberg,et al. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. , 1994, Cell.
[37] G. Franzoso,et al. Structure, regulation and function of NF-kappa B. , 1994, Annual review of cell biology.
[38] E. A. O'neill,et al. Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF‐kappa B. , 1994, The EMBO journal.
[39] E M Schwarz,et al. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.
[40] B. Aggarwal,et al. Protein-tyrosine Phosphatase Inhibitors Block Tumor Necrosis Factor-dependent Activation of the Nuclear Transcription Factor NF-B (*) , 1995, The Journal of Biological Chemistry.
[41] Joseph A. DiDonato,et al. Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.
[42] A. Strasser,et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. , 1995, Genes & development.
[43] David Baltimore,et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.
[44] F. A. La Rosa,et al. Role of the Rel-family of transcription factors in the regulation of c-myc gene transcription and apoptosis of WEHI 231 murine B-cells. , 1995, Current topics in microbiology and immunology.
[45] D. Baltimore,et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. , 1995, Nature.
[46] B. Aggarwal,et al. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. , 1995, The Journal of biological chemistry.
[47] T. Torgerson,et al. Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence (*) , 1995, The Journal of Biological Chemistry.
[48] B. Aggarwal,et al. Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.
[49] V. Castronovo,et al. Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells. , 1995, Oncogene.
[50] David Baltimore,et al. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses , 1995, Cell.
[51] E. A. O'neill,et al. The effect of sodium salicylate and aspirin on NF-kappa B. , 1995, Science.
[52] M. Karin,et al. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. , 1995, Science.
[53] Y. Kitade,et al. Inhibition of the DNA‐binding activity of NF‐κB by gold compounds in vitro , 1995 .
[54] G. Riethmüller,et al. Fas/Apo-1 activates nuclear factor kappa B and induces interleukin-6 production. , 1995, Journal of inflammation.
[55] E. A. O'neill,et al. The Effect of Sodium Salicylate and Aspirin on NF-kappaB , 1995, Science.
[56] Y. Kitade,et al. Inhibition of the DNA-binding activity of NF-kappa B by gold compounds in vitro. , 1995, FEBS letters.
[57] D. Kelleher,et al. Cellular Proliferation and Activation of NFκB Are Induced by Autocrine Production of Tumor Necrosis Factor α in the Human T Lymphoma Line HuT 78 (*) , 1995, The Journal of Biological Chemistry.
[58] D. Baltimore,et al. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. , 1995, Genes & development.
[59] F. Bertrand,et al. Insulin Activates Nuclear Factor κB in Mammalian Cells through a Raf-1-mediated Pathway (*) , 1995, The Journal of Biological Chemistry.
[60] D. Latchman. Cell stress genes and neuronal protection , 1995, Neuropathology and applied neurobiology.
[61] L. Baldini,et al. Molecular analysis of cutaneous B- and T-cell lymphomas. , 1995, Blood.
[62] A. Ding,et al. Activation of NF-kappa B in murine macrophages by taxol. , 1995, Cancer biochemistry biophysics.
[63] H. Pahl,et al. Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B , 1995, Journal of virology.
[64] N. Fausto,et al. Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[65] J. Roth,et al. Altered expression of the p50 subunit of the NF-kappa B transcription factor complex in non-small cell lung carcinoma. , 1995, Oncogene.
[66] David Baltimore,et al. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.
[67] P. Parker,et al. Up-Regulation of Protein Kinase C-ε Promotes the Expression of Cytokine-inducible Nitric Oxide Synthase in RAW 264.7 Cells* , 1996, The Journal of Biological Chemistry.
[68] A. Tarakhovsky,et al. Immunodeficiency in Protein Kinase Cβ-Deficient Mice , 1996, Science.
[69] H. W. Sharma,et al. The NF-kappaB transcription factor in oncogenesis. , 1996, Anticancer research.
[70] B. Aggarwal,et al. Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents. , 1996, Journal of immunology.
[71] F. Bach,et al. Glucocorticoid-mediated Repression of NFκB Activity in Endothelial Cells Does Not Involve Induction of IκBα Synthesis* , 1996, The Journal of Biological Chemistry.
[72] T. H. Wang,et al. p53, apoptosis and human cancers. , 1996, Journal of the Formosan Medical Association = Taiwan yi zhi.
[73] Zhaodan Cao,et al. TRAF6 is a signal transducer for interleukin-1 , 1996, Nature.
[74] F. Bach,et al. Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. , 1996, The Journal of biological chemistry.
[75] C. Y. Wang,et al. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. , 1996, Science.
[76] C. Stewart,et al. IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice , 1996, Molecular and cellular biology.
[77] Hong-Bing Shu,et al. TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.
[78] Marty W. Mayo,et al. TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.
[79] B. Aggarwal,et al. Site-specific Tyrosine Phosphorylation of IκBα Negatively Regulates Its Inducible Phosphorylation and Degradation* , 1996, The Journal of Biological Chemistry.
[80] A. Strasser,et al. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[81] J. Stark,et al. Copyright � 1996, American Society for Microbiology Inhibition of Viral Replication Reverses Respiratory Syncytial Virus-Induced NF-�B Activation and Interleukin-8 Gene , 1996 .
[82] P. Lichter,et al. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. , 1996, Blood.
[83] I. Verma,et al. Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required , 1996, Molecular and cellular biology.
[84] C. Mueller-Dieckmann,et al. Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α , 1996, Cell.
[85] D. Green,et al. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. , 1996, Science.
[86] D. Katz,et al. Inhibition of NF‐kappaB/Rel induces apoptosis of murine B cells. , 1996, The EMBO journal.
[87] D. Baltimore,et al. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. , 1996, Science.
[88] B. Aggarwal,et al. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[89] A. Brasier,et al. Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes. , 1996, Molecular endocrinology.
[90] B. Dörken,et al. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. , 1996, Blood.
[91] D. Goeddel,et al. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[92] Maria Panico,et al. Inhibition of NF-κB DNA Binding by Nitric Oxide , 1996 .
[93] M. Arsura,et al. TGFβ1 Inhibits NF-κB/Rel Activity Inducing Apoptosis of B Cells: Transcriptional Activation of IκBα , 1996 .
[94] K. Schulze-Osthoff,et al. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB , 1996, The Journal of experimental medicine.
[95] D. Baltimore,et al. B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. , 1996, Journal of immunology.
[96] K. Offit,et al. REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma , 1996 .
[97] K. Offit,et al. REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. , 1996, Blood.
[98] M. Arsura,et al. TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha. , 1996, Immunity.
[99] S. Gerondakis,et al. The Rel subunit of NF‐kappaB‐like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. , 1996, The EMBO journal.
[100] H. Takebe,et al. Enhanced radiosensitivity by inhibition of nuclear factor kappa B activation in human malignant glioma cells. , 1996, International journal of radiation biology.
[101] M. Boothby,et al. Perturbation of the T Lymphocyte Lineage In Transgenic Mice Expressing a Constitutive Repressor of Nuclear Factor (NF)-κB , 1997, The Journal of experimental medicine.
[102] David M. Rothwarf,et al. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.
[103] Y. Obata,et al. NF-κB RelA-deficient Lymphocytes: Normal Development of T Cells and B Cells, Impaired Production of IgA and IgG1 and Reduced Proliferative Responses , 1997, The Journal of experimental medicine.
[104] A. Richmond,et al. Enhanced Degradation of I-κBα Contributes to Endogenous Activation of NF-κB in Hs294T Melanoma Cells , 1997 .
[105] H. Erdjument-Bromage,et al. The Transcriptional Activity of NF-κB Is Regulated by the IκB-Associated PKAc Subunit through a Cyclic AMP–Independent Mechanism , 1997, Cell.
[106] A. Rossi,et al. Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[107] Mike Rothe,et al. IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK , 1997 .
[108] G. Courtois,et al. Down-regulation of NF-kappaB activity and NF-kappaB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells. , 1997, Oncogene.
[109] M. C. Hu,et al. Activation of the Hematopoietic Progenitor Kinase-1 (HPK1)-dependent, Stress-activated c-Jun N-terminal Kinase (JNK) Pathway by Transforming Growth Factor β (TGF-β)-activated Kinase (TAK1), a Kinase Mediator of TGF β Signal Transduction* , 1997, The Journal of Biological Chemistry.
[110] A. Richmond,et al. Enhanced degradation of I-kappaB alpha contributes to endogenous activation of NF-kappaB in Hs294T melanoma cells. , 1997, Cancer research.
[111] Riaz-ul-Haq,et al. Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. , 1997, Journal of cardiovascular pharmacology.
[112] A. Lentsch,et al. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. , 1997, The Journal of clinical investigation.
[113] A. E. Rogers,et al. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. , 1997, The Journal of clinical investigation.
[114] W. Liao,et al. Phosphatidylinositol 3-Kinase in Interleukin 1 Signaling , 1997, The Journal of Biological Chemistry.
[115] Matthias Mann,et al. IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .
[116] D. Goeddel,et al. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. , 1997, Science.
[117] G. Courtois,et al. Down-regulation of NF-κB activity and NF-κB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells , 1997, Oncogene.
[118] E. Zandi,et al. The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.
[119] B. Aggarwal,et al. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation. , 1997, The Journal of biological chemistry.
[120] B. Aggarwal,et al. Sanguinarine (Pseudochelerythrine) Is a Potent Inhibitor of NF-κB Activation, IκBα Phosphorylation, and Degradation* , 1997, The Journal of Biological Chemistry.
[121] G. Sledge,et al. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth , 1997, Molecular and cellular biology.
[122] A. Ciechanover,et al. Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase. , 1997, The EMBO journal.
[123] B. Dörken,et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. , 1997, The Journal of clinical investigation.
[124] L. Baldini,et al. Identification of a tumor-associated mutant form of the NF-κB RelA gene with reduced DNA-binding and transactivating activities , 1997, Oncogene.
[125] A. Ciechanover,et al. Inhibition of NF‐κB cellular function via specific targeting of the IκB‐ubiquitin ligase , 1997 .
[126] M. P. Miano,et al. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFκB p65 protein expression , 1997, Oncogene.
[127] Ge Zhou,et al. NF-κB-mediated Induction of mdr1b Expression by Insulin in Rat Hepatoma Cells* , 1997, The Journal of Biological Chemistry.
[128] D. Wallach,et al. MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1 , 1997, Nature.
[129] D. Goeddel,et al. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[130] P. Baeuerle,et al. NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. , 1997, Advances in immunology.
[131] C Gélinas,et al. c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition , 1997, Molecular and cellular biology.
[132] D. Goeddel,et al. Identification and Characterization of an IκB Kinase , 1997, Cell.
[133] A. Palotie,et al. Genomic Organization of Human and Mouse Genes for Vascular Endothelial Growth Factor C* , 1997, The Journal of Biological Chemistry.
[134] C. Y. Wang,et al. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. , 1997, Science.
[135] M. Mayo,et al. Involvement of Egr-1/RelA Synergy in Distinguishing T Cell Activation from Tumor Necrosis Factor-α–induced NF-κB1 Transcription , 1997, The Journal of experimental medicine.
[136] D. Brenner,et al. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. , 1998, The Journal of clinical investigation.
[137] S. Ghosh,et al. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. , 1998, Molecular cell.
[138] J. Cigudosa,et al. Chromosomal and gene amplification in diffuse large B-cell lymphoma. , 1998, Blood.
[139] D. Carbone,et al. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. , 1998, Blood.
[140] B. Aggarwal,et al. Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. , 1998, The Journal of biological chemistry.
[141] T. Kondo,et al. Glutathione downregulates the phosphorylation of I kappa B: autoloop regulation of the NF-kappa B-mediated expression of NF-kappa B subunits by TNF-alpha in mouse vascular endothelial cells. , 1998, Biochemical and biophysical research communications.
[142] D. Brenner,et al. Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells. , 1998, Journal of immunology.
[143] S. Kim,et al. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B. , 1998, Biochemical and biophysical research communications.
[144] F. Holsboer,et al. Induction of NF-κB Activity during Haloperidol-Induced Oxidative Toxicity in Clonal Hippocampal Cells: Suppression of NF-κB and Neuroprotection by Antioxidants , 1998, The Journal of Neuroscience.
[145] H. Döhner,et al. Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract. , 1998, Blood.
[146] S. Manna,et al. Ectopic Expression of Hepatitis C Virus Core Protein Differentially Regulates Nuclear Transcription Factors , 1998, Journal of Virology.
[147] E. Zandi,et al. IKK-γ is an essential regulatory subunit of the IκB kinase complex , 1998, Nature.
[148] P. Tofilon,et al. IkappaBalpha degradation is not a requirement for the X-ray-induced activation of nuclear factor kappaB in normal rat astrocytes and human brain tumour cells. , 1998, International journal of radiation biology.
[149] K. Sumikawa,et al. Glutathione Downregulates the Phosphorylation of IκB: Autoloop Regulation of the NF-κB-Mediated Expression of NF-κB Subunits by TNF-α in Mouse Vascular Endothelial Cells , 1998 .
[150] C. Jongeneel,et al. Survival-independent function of NF-kappaB/Rel during late stages of thymocyte differentiation. , 1998, Molecular immunology.
[151] Chou-Chi H. Li,et al. Association of Cdk2/Cyclin E and NF-κB Complexes at G1/S Phase , 1998 .
[152] R. Freeman,et al. Nerve Growth Factor-Dependent Activation of NF-κB Contributes to Survival of Sympathetic Neurons , 1998, The Journal of Neuroscience.
[153] L. Ehrlich,et al. IL-10 down-regulates human microglial IL-8 by inhibition of NF-kappaB activation. , 1998, Neuroreport.
[154] C. N. Coleman,et al. Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[155] C. Snapper,et al. Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune Responses , 1998, The Journal of experimental medicine.
[156] A. Leonardi,et al. Mice Deficient in Nuclear Factor (NF)-κB/p52 Present with Defects in Humoral Responses, Germinal Center Reactions, and Splenic Microarchitecture , 1998, The Journal of experimental medicine.
[157] E. Muñoz-Elías,et al. Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-Jun* , 1998, The Journal of Biological Chemistry.
[158] A. Barchowsky,et al. Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism. , 1998, Archives of biochemistry and biophysics.
[159] D. Green,et al. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. , 1998, Molecular cell.
[160] R. Hay,et al. Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB. , 1998, Oncogene.
[161] M. Neurath,et al. The yopJ locus is required for Yersinia‐mediated inhibition of NF‐κB activation and cytokine expression: YopJ contains a eukaryotic SH2‐like domain that is essential for its repressive activity , 1998, Molecular microbiology.
[162] Howard Hughes. Lactacystin, Proteasome Function, and Cell Fate* , 1998, The Journal of Biological Chemistry.
[163] E. Jimi,et al. Activation of NF-κB Is Involved in the Survival of Osteoclasts Promoted by Interleukin-1* , 1998, The Journal of Biological Chemistry.
[164] K. Harano,et al. An allosteric drug, o,o'-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B. , 1998, Biochemical and biophysical research communications.
[165] S. Manna,et al. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis. , 1998, Journal of immunology.
[166] D. Carbone,et al. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. , 1998, Journal of immunology.
[167] M. Shichiri,et al. NO Inhibits Cytokine-Induced iNOS Expression and NF-κB Activation by Interfering With Phosphorylation and Degradation of IκB-α , 1998 .
[168] W. El-Deiry,et al. p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. , 1998, Cancer research.
[169] J. Troppmair,et al. Activation of NF-κB by oncogenic Raf in HEK 293 cells occurs through autocrine recruitment of the stress kinase cascade , 1998, Oncogene.
[170] D. Brenner,et al. Mediation by NF-κB of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors , 1998, Gut.
[171] M. Shichiri,et al. NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[172] Jian-Dong Li,et al. Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[173] Zhaodan Cao,et al. NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176 , 1998 .
[174] S. Paul,et al. The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation. , 1998, Brain research. Molecular brain research.
[175] A. Vollmar,et al. The guanylate cyclase–coupled natriuretic peptide receptor: A new target for prevention of cold ischemia–reperfusion damage of the rat liver , 1998, Hepatology.
[176] B. Binder,et al. Cytokine induced expression of porcine inhibitor of apoptosis protein (iap) family member is regulated by NF-kappa B. , 1998, Biochemical and biophysical research communications.
[177] A. Strasser,et al. B Lymphocytes Differentially Use the Rel and Nuclear Factor κB1 (NF-κB1) Transcription Factors to Regulate Cell Cycle Progression and Apoptosis in Quiescent and Mitogen-activated Cells , 1998, The Journal of experimental medicine.
[178] S. Paul,et al. The NF-κB/Rel family of proteins mediates Aβ-induced neurotoxicity and glial activation , 1998 .
[179] R. Hotchkiss,et al. Nitric oxide inhibits stress-induced endothelial cell apoptosis. , 1998, Critical care medicine.
[180] S. Gerondakis,et al. The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation. , 1998, Current opinion in immunology.
[181] S. Manna,et al. Interleukin-4 Down-regulates Both Forms of Tumor Necrosis Factor Receptor and Receptor-mediated Apoptosis, NF-κB, AP-1, and c-Jun N-Terminal Kinase , 1998, The Journal of Biological Chemistry.
[182] R. Hay,et al. Defective IκBα in Hodgkin cell lines with constitutively active NF-κB , 1998, Oncogene.
[183] Ebrahim Zandi,et al. Direct Phosphorylation of IκB by IKKα and IKKβ: Discrimination Between Free and NF-κB-Bound Substrate , 1998 .
[184] M. Merville,et al. Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugs. , 1999, Cancer research.
[185] T. Okamoto,et al. Identification of a Novel Inhibitor of Nuclear Factor-κB, RelA-associated Inhibitor* , 1999, The Journal of Biological Chemistry.
[186] T. Maniatis,et al. A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways. , 1999, Genes & development.
[187] L. Pfeffer,et al. NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase , 1999, Nature.
[188] C. Jongeneel,et al. Efficient adenoviral transfer of NF‐κB inhibitor sensitizes melanoma to tumor necrosis factor‐mediated apoptosis , 1999, International journal of cancer.
[189] G. Ghosh,et al. Regulation of DNA binding by Rel/NF-κB transcription factors: structural views , 1999, Oncogene.
[190] S. Akira,et al. Limb and skin abnormalities in mice lacking IKKalpha. , 1999, Science.
[191] H. Kato,et al. NF-κB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2 , 1999, Oncogene.
[192] T. Deerinck,et al. Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase , 1999 .
[193] D. Brenner,et al. IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death. , 1999, American journal of respiratory cell and molecular biology.
[194] M. Diaz-Meco,et al. The interaction of p62 with RIP links the atypical PKCs to NF‐κB activation , 1999, The EMBO journal.
[195] A. Manning,et al. NF-κB as a primary regulator of the stress response , 1999, Oncogene.
[196] C. Justicia,et al. Activation of nuclear factor-κB in the rat brain after transient focal ischemia , 1999 .
[197] Xianglin Shi,et al. Vanadate Induction of NF-κB Involves IκB Kinase β and SAPK/ERK Kinase 1 in Macrophages* , 1999, The Journal of Biological Chemistry.
[198] A. Farr,et al. Oxidative Stress Induces NF-κB Nuclear Translocation Without Degradation of IκBα , 1999 .
[199] Michael Karin,et al. Is NF‐κB the sensor of oxidative stress? , 1999 .
[200] T. Deerinck,et al. The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis , 1999, The Journal of experimental medicine.
[201] U. Engelmann,et al. Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer. , 1999, Urology.
[202] W. Erl,et al. Nuclear factor-κB regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells , 1999 .
[203] B. Rayet,et al. Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.
[204] D. Baltimore,et al. NF‐κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK‐related kinase , 1999, The EMBO journal.
[205] C. Van Waes,et al. Constitutive activation of transcription factors NF‐κB, AP‐1, and NF‐IL6 in human head and neck squamous cell carcinoma cell lines that express pro‐inflammatory and pro‐angiogenic cytokines , 1999, Molecular carcinogenesis.
[206] M. Karin,et al. Is NF-kappaB the sensor of oxidative stress? , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[207] F. Vittimberga,et al. Ubiquitin-proteasome inhibition enhances apoptosis of human pancreatic cancer cells. , 1999, Surgery.
[208] W. Erl,et al. Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. , 1999, Circulation research.
[209] Douglas B. Evans,et al. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA , 1999, Oncogene.
[210] N. Perkins,et al. Transcriptional cross talk between NF-kappaB and p53. , 1999, Molecular and cellular biology.
[211] H. Kato,et al. NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2. , 1999, Oncogene.
[212] F. Uckun,et al. Innovative treatment programs against cancer: II. nuclear factor-κB (NF-κB) as a molecular target , 1999 .
[213] P. Elliott,et al. Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome. , 1999, Methods in enzymology.
[214] S. Akira,et al. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. , 1999, International immunology.
[215] N. Perkins,et al. Transcriptional Cross Talk between NF-κB and p53 , 1999, Molecular and Cellular Biology.
[216] J. Liao,et al. Assessing induction of I kappa B by nitric oxide. , 1999, Methods in enzymology.
[217] L. Johnston,et al. TPL-2 kinase regulates the proteolysis of the NF-κB-inhibitory protein NF-κB1 p105 , 1999, Nature.
[218] B. Kahn-Perlès,et al. Physical interaction of the bHLH LYL1 protein and NF-κB1 p105 , 1999, Oncogene.
[219] M. Diaz-Meco,et al. Inactivation of the Inhibitory κB Protein Kinase/Nuclear Factor κB Pathway by Par-4 Expression Potentiates Tumor Necrosis Factor α-induced Apoptosis* , 1999, The Journal of Biological Chemistry.
[220] S. Gerondakis,et al. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. , 1999, Genes & development.
[221] K. Vousden,et al. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. , 1999, Molecular cell.
[222] J. Liao,et al. Assessing induction of I?B by nitric oxide , 1999 .
[223] Claus Scheidereit,et al. NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition , 1999, Molecular and Cellular Biology.
[224] B. Dörken,et al. Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells , 1999, Oncogene.
[225] M. Tomonaga,et al. Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells. , 1999, Blood.
[226] M. Ueffing,et al. Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB. , 1999, Oncogene.
[227] B. Kahn-Perlès,et al. Physical interaction of the bHLH LYL1 protein and NF-kappaB1 p105. , 1999, Oncogene.
[228] D. Goeddel,et al. Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient Mice , 1999 .
[229] T. Ito,et al. Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivo. , 1999, American journal of respiratory cell and molecular biology.
[230] M. Diaz,et al. Role of NF-kappaB in the apoptotic-resistant phenotype of keratinocytes. , 1999, The Journal of biological chemistry.
[231] M. Ueffing,et al. Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-κB , 1999, Oncogene.
[232] A. Miyajima,et al. An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells. , 1999, The Journal of urology.
[233] Chris Albanese,et al. NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 , 1999, Molecular and Cellular Biology.
[234] Markus Schwaninger,et al. NF-κB is activated and promotes cell death in focal cerebral ischemia , 1999, Nature Medicine.
[235] C. Haslett,et al. NF-κB Activation Is a Critical Regulator of Human Granulocyte Apoptosis in Vitro* , 1999, The Journal of Biological Chemistry.
[236] Yukio Nakamura,et al. Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts , 1999, Oncogene.
[237] Douglas B. Evans,et al. The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells , 1999 .
[238] R. Hay,et al. Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. , 1999, Oncogene.
[239] M. C. Hu,et al. Hematopoietic progenitor kinase-1 (HPK1) stress response signaling pathway activates IκB kinases (IKK-α/β) and IKK-β is a developmentally regulated protein kinase , 1999, Oncogene.
[240] T. Gilmore,et al. Diverse agents act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway , 1999, Oncogene.
[241] D. Brenner,et al. I κ B α Gene Transfer Is Cytotoxic to Squamous-Cell Lung Cancer Cells and Sensitizes Them to Tumor Necrosis Factor- α –Mediated Cell Death , 1999 .
[242] H. Pahl. Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.
[243] C. Van Waes,et al. The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma. , 1999, Cancer research.
[244] C. N. Coleman,et al. Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen , 1999, Oncogene.
[245] B. Brüne,et al. Superoxide attenuates macrophage apoptosis by NF-kappa B and AP-1 activation that promotes cyclooxygenase-2 expression. , 1999, Journal of immunology.
[246] R. Kao,et al. Early activation of transcription factor NF-κB during ischemia in perfused rat heart. , 1999, American journal of physiology. Heart and circulatory physiology.
[247] B. Barlogie,et al. Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. , 1999, Blood.
[248] C. N. Coleman,et al. Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. , 1999, Oncogene.
[249] N. Shimizu,et al. Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated IkappaBalpha overexpression. , 1999, Human gene therapy.
[250] A. Martin-Villalba,et al. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. , 1999, Nature medicine.
[251] J. Cusack,et al. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB , 1999, Nature Medicine.
[252] Marty W. Mayo,et al. NF-κB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 To Preferentially Suppress Chemotherapy-Induced Apoptosis , 1999, Molecular and Cellular Biology.
[253] T. Chase,et al. Nuclear Factor κB Nuclear Translocation Upregulates c-Myc and p53 Expression during NMDA Receptor-Mediated Apoptosis in Rat Striatum , 1999, The Journal of Neuroscience.
[254] G. Stark,et al. IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family* , 1999, The Journal of Biological Chemistry.
[255] L. Owen-Schaub,et al. Activation-Dependent Transcriptional Regulation of the Human fas Promoter Requires NF-κB p50-p65 Recruitment , 1999, Molecular and Cellular Biology.
[256] Quan Zhao,et al. Mitogen-activated Protein Kinase/ERK Kinase Kinases 2 and 3 Activate Nuclear Factor-κB through IκB Kinase-α and IκB Kinase-β* , 1999, The Journal of Biological Chemistry.
[257] M. Diaz,et al. Role of NF-κB in the Apoptotic-resistant Phenotype of Keratinocytes* , 1999, The Journal of Biological Chemistry.
[258] Inder M. Verma,et al. Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene , 1999 .
[259] H. Pahl,et al. Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.
[260] R. Hay,et al. Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα , 1999, Oncogene.
[261] J. Abbruzzese,et al. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[262] M. Karin. How NF-κB is activated: the role of the IκB kinase (IKK) complex , 1999, Oncogene.
[263] Ching-Chow Chen,et al. TNF-α-Induced Cyclooxygenase-2 Expression in Human Lung Epithelial Cells: Involvement of the Phospholipase C-γ2, Protein Kinase C-α, Tyrosine Kinase, NF-κB-Inducing Kinase, and I-κB Kinase 1/2 Pathway1 , 2000, The Journal of Immunology.
[264] S. Akira,et al. NF‐κB activation through IKK‐i‐dependent I‐TRAF/TANK phosphorylation , 2000, Genes to cells : devoted to molecular & cellular mechanisms.
[265] T. Maniatis,et al. IKKε is part of a novel PMA-inducible IkappaB kinase complex. Molecular Cell 5:513-522 , 2000 .
[266] C. Scheidereit,et al. Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells , 2000, Leukemia.
[267] S. Thorgeirsson,et al. Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells. , 2000, Molecular and cellular biology.
[268] X. Sun,et al. p300/CBP-dependent and -independent transcriptional interference between NF-kappaB RelA and p53. , 2000, Biochemical and biophysical research communications.
[269] M. Toyota,et al. Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors. , 2000, Cancer research.
[270] N. K. Sah,et al. Protein Tyrosine Kinase p56 lck Is Required for Ceramide-induced but Not Tumor Necrosis Factor-induced Activation of NF-κB, AP-1, JNK, and Apoptosis* , 2000, The Journal of Biological Chemistry.
[271] Y. L. Li,et al. Effects of antisense IRAK-2 oligonucleotides on PGI2 release induced by IL-1 and TNF. , 2000, Acta pharmacologica Sinica.
[272] Klaus Rajewsky,et al. NEMO/IKKγ-Deficient Mice Model Incontinentia Pigmenti , 2000 .
[273] K. Vousden,et al. Role of NF-kappaB in p53-mediated programmed cell death. , 2000, Nature.
[274] C. Harris,et al. Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor. , 2000, Cancer research.
[275] M. Karin,et al. NAK is an IκB kinase-activating kinase , 2000, Nature.
[276] W. Khan,et al. Bruton's Tyrosine Kinase Is Required for Activation of Iκb Kinase and Nuclear Factor κb in Response to B Cell Receptor Engagement , 2000, The Journal of experimental medicine.
[277] S. Ghosh,et al. Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex , 2000 .
[278] S. Thorgeirsson,et al. Role of the IκB Kinase Complex in Oncogenic Ras- and Raf-Mediated Transformation of Rat Liver Epithelial Cells , 2000, Molecular and Cellular Biology.
[279] M. Mattson,et al. Pro‐apoptotic action of PAR‐4 involves inhibition of NF‐κB activity and suppression of BCL‐2 expression , 2000, Journal of neuroscience research.
[280] N. Perkins,et al. Inhibition of the RelA(p65) NF-kappaB subunit by Egr-1. , 2000, The Journal of biological chemistry.
[281] A. Vertegaal. Protein kinase C-$alpha; is an upstream activator of the I$kappa;B kinase complex in the TPA signal transduction pathway to NF-$kappa;B in U2OS cells , 2000 .
[282] W. Greene,et al. Protein Kinase C-θ Participates in NF-κB Activation Induced by CD3-CD28 Costimulation through Selective Activation of IκB Kinase β , 2000, Molecular and Cellular Biology.
[283] T. Mak,et al. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF‐κB‐dependent gene transcription , 2000, The EMBO journal.
[284] N. Perkins,et al. Inhibition of the RelA(p65) NF-κB Subunit by Egr-1* , 2000, The Journal of Biological Chemistry.
[285] T. Hofmann,et al. Mixed-Lineage Kinase 3 Delivers CD3/CD28-Derived Signals into the IκB Kinase Complex , 2000, Molecular and Cellular Biology.
[286] J. Frost,et al. Stimulation of NFκB Activity by Multiple Signaling Pathways Requires PAK1* , 2000, The Journal of Biological Chemistry.
[287] T. Maniatis,et al. IKKε Is Part of a Novel PMA-Inducible IκB Kinase Complex , 2000 .
[288] F. D’Acquisto,et al. Local administration of transcription factor decoy oligonucleotides to nuclear factor-κB prevents carrageenin-induced inflammation in rat hind paw , 2000, Gene Therapy.
[289] K. Vousden,et al. Role of NF-κB in p53-mediated programmed cell death , 2000, Nature.
[290] M. Torii,et al. Effects of roxithromycin on tumor necrosis factor-alpha-induced vascular endothelial growth factor expression in human periodontal ligament cells in culture. , 2000, Journal of periodontology.
[291] J. Pober,et al. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. , 2000, Science.
[292] H. Saji,et al. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[293] I. Nishimoto,et al. Prognostic Significance of the Combined Expression of Matrix Metalloproteinase-9, Urokinase Type Plasminogen Activator and its Receptor in Breast Cancer as Measured by Northern Blot Analysis , 2001, The International journal of biological markers.
[294] A. Kalgutkar,et al. Discovery and design of selective cyclooxygenase-2 inhibitors as non-ulcerogenic, anti-inflammatory drugs with potential utility as anti-cancer agents. , 2001, Current drug targets.
[295] M. Karin,et al. IKKβ Is Essential for Protecting T Cells from TNFα-Induced Apoptosis , 2001 .
[296] V. Rangnekar,et al. Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression. , 2001, Cancer research.
[297] P. Elliott,et al. Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. , 2001, International journal of radiation oncology, biology, physics.
[298] T. Mak,et al. Bimp1, a MAGUK Family Member Linking Protein Kinase C Activation to Bcl10-mediated NF-κB Induction* , 2001, The Journal of Biological Chemistry.
[299] J. Clohisy,et al. TAT Fusion Proteins Containing Tyrosine 42-deleted IκBα Arrest Osteoclastogenesis* , 2001, The Journal of Biological Chemistry.
[300] F. Balkwill,et al. Epithelial cancer cell migration: a role for chemokine receptors? , 2001, Cancer research.
[301] Stuart A. Lipton,et al. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades , 2001, Nature.
[302] B. Schraven,et al. Complex Formation and Cooperation of Protein Kinase Cθ and Akt1/Protein Kinase Bα in the NF-κB Transactivation Cascade in Jurkat T Cells* , 2001, The Journal of Biological Chemistry.
[303] R. Strieter. Chemokines: Not just leukocyte chemoattractants in the promotion of cancer , 2001, Nature Immunology.
[304] M. Hitt,et al. Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity , 2001, Gene Therapy.
[305] W. Greene,et al. Duration of nuclear NF-kappaB action regulated by reversible acetylation. , 2001, Science.
[306] W. Liao,et al. The essential role of MEKK3 in TNF-induced NF-κB activation , 2001, Nature Immunology.
[307] U. Mazurek,et al. [Vascular endothelial growth factor (VEGF) and its role in neoplastic processes]. , 2001, Postepy higieny i medycyny doswiadczalnej.
[308] T. Gilmore,et al. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel , 2001, Oncogene.
[309] Michael Karin,et al. Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.
[310] P. Elliott,et al. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. , 2001, Cancer research.
[311] T. Ichikura,et al. Significant correlation between expression of interleukin‐1α and liver metastasis in gastric carcinoma , 2001, Cancer.
[312] I. Vancurova,et al. NF-kappaB Activation in TNFalpha-Stimulated Neutrophils is Mediated by Protein Kinase C-delta: Correlation to Nuclear I-kappaB-alpha , 2001 .
[313] L. Marnett,et al. IκB Kinase, a Molecular Target for Inhibition by 4-Hydroxy-2-nonenal* , 2001, The Journal of Biological Chemistry.
[314] T. Muta,et al. A Novel IκB Protein, IκB-ζ, Induced by Proinflammatory Stimuli, Negatively Regulates Nuclear Factor-κB in the Nuclei* , 2001, The Journal of Biological Chemistry.
[315] L. Marnett,et al. IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal. , 2001, The Journal of biological chemistry.
[316] R. Fridman,et al. Differential regulation of matrix metalloproteinase‐9, tissue inhibitor of metalloproteinase‐1 (TIMP‐1) and TIMP‐2 expression in co‐cultures of prostate cancer and stromal cells , 2001, International journal of cancer.
[317] Eric Verdin,et al. Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation , 2001, Science.
[318] G. W. Peet,et al. Novel NEMO/IκB Kinase and NF-κB Target Genes at the Pre-B to Immature B Cell Transition* , 2001, The Journal of Biological Chemistry.
[319] Transactivation by the p65 Subunit of NF-κB in Response to Interleukin-1 (IL-1) Involves MyD88, IL-1 Receptor-Associated Kinase 1, TRAF-6, and Rac1 , 2001, Molecular and Cellular Biology.
[320] T. Yoshikawa,et al. The possible role of TNF-α and IL-2 in inducing tumor-associated metabolic alterations , 2004, Surgery Today.